Literature DB >> 13215729

The chemical control of cancer.

J F HOLLAND.   

Abstract

Entities:  

Keywords:  CHEMOTHERAPY; NEOPLASMS/therapy

Mesh:

Year:  1954        PMID: 13215729      PMCID: PMC2024492     

Source DB:  PubMed          Journal:  Public Health Rep        ISSN: 0094-6214            Impact factor:   2.792


× No keyword cloud information.
  55 in total

1.  Demonstration of protection against the lethal toxicity of 6-mercaptopurine in mice.

Authors:  A GOLDIN
Journal:  J Natl Cancer Inst       Date:  1954-06       Impact factor: 13.506

2.  Lack of effect of hypophysectomy upon metastatic adrenocortical carcinoma with Cushing's syndrome: a case report.

Authors:  A I KNOWLTON; J L POOL; J W JAILER
Journal:  J Clin Endocrinol Metab       Date:  1954-02       Impact factor: 5.958

3.  Evaluation of endocrine therapy for advanced breast cancer.

Authors:  O H PEARSON; C D WEST; V P HOLLANDER; N E TREVES
Journal:  J Am Med Assoc       Date:  1954-01-16

4.  Myleran in chronic myeloid leukaemia; results of treatment.

Authors:  D A GALTON
Journal:  Lancet       Date:  1953-01-31       Impact factor: 79.321

5.  Resistance in leukemic cells to an adenine antagonist, 6-mercaptopurine.

Authors:  L W LAW
Journal:  Proc Soc Exp Biol Med       Date:  1953-11

6.  Triethylene melamine in the treatment of neoplastic disease.

Authors:  R W RUNDLES; W B BARTON
Journal:  Blood       Date:  1952-05       Impact factor: 22.113

7.  Folic acid antagonists.

Authors:  H G PETERING
Journal:  Physiol Rev       Date:  1952-04       Impact factor: 37.312

8.  Triethylene melamine in the treatment of neoplastic disease; a compound with nitrogen-mustardlike activity suitable for oral and intravenous use.

Authors:  D A KARNOFSKY; J H BURCHENAL; G C ARMISTEAD; C M SOUTHAM; J L BERNSTEIN; L F CRAVER; C P RHOADS
Journal:  AMA Arch Intern Med       Date:  1951-04

9.  In vivo combinations between carcinogens and tissue constituents and their possible role in carcinogenesis.

Authors:  E C MILLER; J A MILLER
Journal:  Cancer Res       Date:  1952-08       Impact factor: 12.701

10.  Treatment of leukemia with triethylene thiophosphoramide (thio-TEPA); preliminary results in experimental and clinical leukemia.

Authors:  H SHAY; C ZARAFONETIS; N SMITH; I WOLDOW; D C SUN
Journal:  AMA Arch Intern Med       Date:  1953-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.